Artificial intelligence in bronchopulmonary dysplasia- current research and unexplored frontiers.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
01 2023
Historique:
received: 15 04 2022
accepted: 30 10 2022
revised: 21 10 2022
pubmed: 18 11 2022
medline: 25 2 2023
entrez: 17 11 2022
Statut: ppublish

Résumé

Provide an overview of bronchopulmonary dysplasia, its definitions, and their shortcomings. Explore the areas where machine learning may be used to further our understanding of bronchopulmonary dysplasia.

Identifiants

pubmed: 36385519
doi: 10.1038/s41390-022-02387-z
pii: 10.1038/s41390-022-02387-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-290

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Geetha, O. et al. New Bpd-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤ 28 weeks. J. Perinatol. 41, 1943–1950 (2021).
doi: 10.1038/s41372-021-01095-6 pubmed: 34031514 pmcid: 8280382
Bonadies, L. et al. Present and future of bronchopulmonary dysplasia. J. Clin. Med. 9, 1539 (2020).
Rysavy, M. A. et al. Assessment of an updated neonatal research network extremely preterm birth outcome model in the vermont oxford network. JAMA Pediatr. 174, e196294 (2020).
doi: 10.1001/jamapediatrics.2019.6294 pubmed: 32119065 pmcid: 7052789
Northway, W. H., Rosan, R. C. & Porter, D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. N. Engl. J. Med. 276, 357–368 (1967).
doi: 10.1056/NEJM196702162760701 pubmed: 5334613
Patel, A. R., Patel, A. R., Singh, S., Singh, S. & Khawaja, I. Global initiative for chronic obstructive lung disease: the changes made. Cureus 11, e4985 (2019).
pubmed: 31453045 pmcid: 6701900
Iheanacho, I., Zhang, S., King, D., Rizzo, M. & Ismaila, A. S. Economic burden of chronic obstructive pulmonary disease (Copd): a systematic literature review. Int J. Chron. Obstruct Pulmon Dis. 15, 439–460 (2020).
doi: 10.2147/COPD.S234942 pubmed: 32161455 pmcid: 7049777
Jobe, A. H. The new bronchopulmonary dysplasia. Curr. Opin. Pediatr. 23, 167–172 (2011).
doi: 10.1097/MOP.0b013e3283423e6b pubmed: 21169836 pmcid: 3265791
Bhandari, V. Designing a better definition of bronchopulmonary dysplasia. Pediatr. Pulmonol. 54, 678–679 (2019).
doi: 10.1002/ppul.24305 pubmed: 30864236
Isayama, T. et al. Revisiting the definition of bronchopulmonary dysplasia. JAMA Pediatrics 171, 271 (2017).
doi: 10.1001/jamapediatrics.2016.4141 pubmed: 28114678
Higgins, R. D. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J. Pediatr. 197, 300–308 (2018).
doi: 10.1016/j.jpeds.2018.01.043 pubmed: 29551318 pmcid: 5970962
Smith, V. C. et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J. Pediatrics 144, 799–803 (2004).
Lapcharoensap, W., Lee, H. C., Nyberg, A. & Dukhovny, D. Health care and societal costs of bronchopulmonary dysplasia. Neoreviews 19, e211–e223 (2018).
doi: 10.1542/neo.19-4-e211 pubmed: 33384574 pmcid: 7773141
Van Marter, L. J. et al. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch. Dis. Child Fetal Neonatal Ed. 96, F20–F29 (2011).
doi: 10.1136/adc.2010.183012 pubmed: 20736416
Twilhaar, E. S. et al. Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression. JAMA Pediatr. 172, 361–367 (2018).
doi: 10.1001/jamapediatrics.2017.5323 pubmed: 29459939 pmcid: 5875339
Morag, I. et al. Predictors of developmental and respiratory outcomes among preterm infants with bronchopulmonary dysplasia. Front Pediatr. 9, 780518 (2021).
Jeon, G. W., Oh, M. & Chang, Y. S. Definitions of bronchopulmonary dysplasia and long-term outcomes of extremely preterm infants in korean neonatal network. Sci. Rep. 11, 24349 (2021).
doi: 10.1038/s41598-021-03644-7 pubmed: 34934085 pmcid: 8692520
Hintz, S. R., Kendrick, D. E., Vohr, B. R., Poole, W. K. & Higgins, R. D. Changes in neurodevelopmental outcomes at 18 to 22 months’ corrected age among infants of less than 25 weeks’ gestational age born in 1993–1999. Pediatrics 115, 1645–1651 (2005).
doi: 10.1542/peds.2004-2215 pubmed: 15930228
Doyle, L. W. et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 118, 108–113 (2006).
doi: 10.1542/peds.2005-2522 pubmed: 16818555
Choi, E. K., Shin, S. H., Kim, E. K. & Kim, H. S. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18–24 months of corrected age. BMC Pediatr. 19, 26 (2019).
Han, Y. S., Kim, S. H. & Sung, T. J. Impact of the definition of bronchopulmonary dysplasia on neurodevelopmental outcomes. Sci. Rep. 11, 22589 (2021).
doi: 10.1038/s41598-021-01219-0 pubmed: 34799575 pmcid: 8605019
Saengrat, P. & Limrungsikul, A. predictive ability of the new bronchopulmonary dysplasia definition on pulmonary outcomes at 20 to 24 months’ corrected age of preterm infants. Am. J. Perinatol. https://doi.org/10.1055/s-0041-1735219 (2021).
Vyas-Read, S. et al. A comparison of newer classifications of bronchopulmonary dysplasia: findings from the children’s hospitals neonatal consortium severe Bpd group. J. Perinatol. 42, 58–64 (2022).
doi: 10.1038/s41372-021-01178-4 pubmed: 34354227
Laughon, M. M. et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am. J. Respir. Crit. Care Med 183, 1715–1722 (2011).
doi: 10.1164/rccm.201101-0055OC pubmed: 21471086 pmcid: 3136997
Saglani, S. & Custovic, A. Childhood asthma: advances using machine learning and mechanistic studies. Am. J. Respiratory Crit. Care Med. 199, 414–422 (2019).
doi: 10.1164/rccm.201810-1956CI
Verder, H. et al. Bronchopulmonary dysplasia predicted at birth by artificial intelligence. Acta Paediatr. 110, 503–509 (2021).
doi: 10.1111/apa.15438 pubmed: 32569404
Dai, D. et al. Bronchopulmonary dysplasia predicted by developing a machine learning model of genetic and clinical information. Front Genet. 12, 689071 (2021).
Ochab, M. & Wajs, W. Expert system supporting an early prediction of the bronchopulmonary dysplasia. Comput Biol. Med 69, 236–244 (2016).
doi: 10.1016/j.compbiomed.2015.08.016 pubmed: 26382937
Shepherd, E. G. et al. Infant pulmonary function testing and phenotypes in severe bronchopulmonary dysplasia. Pediatrics 141, e20173350 (2018).
doi: 10.1542/peds.2017-3350 pubmed: 29622720
Jensen, E. A. & Schmidt, B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res. Part A: Clin. Mol. Teratol. 100, 145–157 (2014).
doi: 10.1002/bdra.23235
Ochiai, M. et al. A new scoring system for computed tomography of the chest for assessing the clinical status of bronchopulmonary dysplasia. J. Pediatrics 152, 90–95.e93 (2008).
doi: 10.1016/j.jpeds.2007.05.043
Yoder, L. M. et al. Elevated lung volumes in neonates with bronchopulmonary dysplasia measured via Mri. Pediatr. Pulmonol. 54, 1311–1318 (2019).
pubmed: 31134768
Ying, X. An overview of overfitting and its solutions. J. Phys.: Conf. Ser. 1168, 022022 (2019).
Khurshid, F. et al. Comparison of multivariable logistic regression and machine learning models for predicting bronchopulmonary dysplasia or death in very preterm infants. Front Pediatr. 9, 759776 (2021).
Dhindsa, K., Bhandari, M. & Sonnadara, R. R. What’s holding up the big data revolution in healthcare? BMJ 363, k5357 (2018).
doi: 10.1136/bmj.k5357 pubmed: 30593447
Castelvecchi, D. Can we open the black box of Ai? Nature 538, 20–23 (2016).
doi: 10.1038/538020a pubmed: 27708329
Rudin, C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat. Mach. Intell. 1, 206–215 (2019).
doi: 10.1038/s42256-019-0048-x pubmed: 35603010 pmcid: 9122117
Quinn, T. P., Jacobs, S., Senadeera, M., Le, V. & Coghlan, S. The three ghosts of medical Ai: can the black-box present deliver? Artif. Intell. Med. 124, 102158 (2022).
doi: 10.1016/j.artmed.2021.102158 pubmed: 34511267
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G. & King, D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 17, 195 (2019).
doi: 10.1186/s12916-019-1426-2 pubmed: 31665002 pmcid: 6821018
Guo, L. L. et al. Systematic review of approaches to preserve machine learning performance in the presence of temporal dataset shift in clinical medicine. Appl Clin. Inf. 12, 808–815 (2021).
doi: 10.1055/s-0041-1735184

Auteurs

Manan Shah (M)

Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA. Manan.a.shah@rutgers.edu.

Deepak Jain (D)

Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.

Surya Prasath (S)

University of Cincinnati, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Kevin Dufendach (K)

University of Cincinnati, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH